Halozyme
HALO
167 hedge funds and large institutions have $1.56B invested in Halozyme in 2017 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 76 increasing their positions, 41 reducing their positions, and 18 closing their positions.
710% more call options, than puts
Call options by funds: $34.9M | Put options by funds: $4.3M
85% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 41
39% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 18
4% more funds holding
Funds holding: 160 → 167 (+7)
5% more capital invested
Capital invested by funds: $1.49B → $1.56B (+$69.7M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.48% less ownership
Funds ownership: 88.71% → 87.22% (-1.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
MSD Partners
New York
|
+$19.8M |
| 2 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$12.7M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$11.3M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.1M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$7.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$20M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.06M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.87M |
| 4 |
JP Morgan Chase
New York
|
-$3.18M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$2.59M |
HALO Hedge Fund Activity: Q2 2017 in Review
167 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q2 2017, worth a combined $1.56B — up 4.7% from $1.49B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new HALO positions and 18 closed out — a net gain of 7 holders — while 76 added to existing stakes and 41 trimmed.
The largest buyer was MSD Partners, adding an estimated $19.8M. The largest seller was VOYA Investment Management, cutting an estimated $20M.
- 167 institutional investors held Halozyme (HALO) as of Q2 2017, up from 160 in Q1 2017.
- Funds reported $1.56B of Halozyme stock for Q2 2017, up 4.7% quarter-over-quarter.
- 25 funds opened new Halozyme positions in Q2 2017 and 18 closed out, a net change of +7 holders.
- The largest Halozyme buyer in Q2 2017 was MSD Partners, an estimated $19.8M added.
- The largest Halozyme seller in Q2 2017 was VOYA Investment Management, an estimated $20M sold.
Based on aggregated 13F filings for Q2 2017.